Literature DB >> 12408750

Control of human carnitine palmitoyltransferase II gene transcription by peroxisome proliferator-activated receptor through a partially conserved peroxisome proliferator-responsive element.

María J Barrero1, Nuria Camarero, Pedro F Marrero, Diego Haro.   

Abstract

The expression of several genes involved in fatty acid metabolism is regulated by peroxisome proliferator-activated receptors (PPARs). To gain more insight into the control of carnitine palmitoyltransferase (CPT) gene expression, we examined the transcriptional regulation of the human CPT II gene. We show that the 5'-flanking region of this gene is transcriptionally active and binds PPARalpha in vivo in a chromatin immunoprecipitation assay. In addition, we characterized the peroxisome proliferator-responsive element (PPRE) in the proximal promoter of the CPT II gene, which appears to be a novel PPRE. The sequence of this PPRE contains one half-site which is a perfect consensus sequence (TGACCT) but no clearly recognizable second half-site (CAGCAC); this part of the sequence contains only one match to the consensus, which seems to be irrelevant for the binding of PPARalpha. As expected, other members of the nuclear receptor superfamily also bind to this element and repress the activation mediated by PPARalpha, thus showing that the interplay between several nuclear receptors may regulate the entry of fatty acids into the mitochondria, a crucial step in their metabolism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12408750      PMCID: PMC1223125          DOI: 10.1042/BJ20020851

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

1.  The orphan nuclear receptor estrogen-related receptor alpha is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene.

Authors:  R Sladek; J A Bader; V Giguère
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5'-flanking region.

Authors:  C Juge-Aubry; A Pernin; T Favez; A G Burger; W Wahli; C A Meier; B Desvergne
Journal:  J Biol Chem       Date:  1997-10-03       Impact factor: 5.157

3.  Polarity and specific sequence requirements of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element.

Authors:  A IJpenberg; E Jeannin; W Wahli; B Desvergne
Journal:  J Biol Chem       Date:  1997-08-08       Impact factor: 5.157

4.  Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor.

Authors:  B A Laffitte; H R Kast; C M Nguyen; A M Zavacki; D D Moore; P A Edwards
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

5.  Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor alpha associated with age-dependent cardiac toxicity.

Authors:  K Watanabe; H Fujii; T Takahashi; M Kodama; Y Aizawa; Y Ohta; T Ono; G Hasegawa; M Naito; T Nakajima; Y Kamijo; F J Gonzalez; T Aoyama
Journal:  J Biol Chem       Date:  2000-07-21       Impact factor: 5.157

6.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction.

Authors:  S N Ho; H D Hunt; R M Horton; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

7.  Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor alpha in HepG2 cells.

Authors:  M H Hsu; U Savas; K J Griffin; E F Johnson
Journal:  J Biol Chem       Date:  2001-05-22       Impact factor: 5.157

8.  Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting.

Authors:  T Hashimoto; W S Cook; C Qi; A V Yeldandi; J K Reddy; M S Rao
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

9.  Reduced hepatic fatty acid oxidation in fasting PPARalpha null mice is due to impaired mitochondrial hydroxymethylglutaryl-CoA synthase gene expression.

Authors:  C Le May; T Pineau; K Bigot; C Kohl; J Girard; J P Pégorier
Journal:  FEBS Lett       Date:  2000-06-23       Impact factor: 4.124

10.  Long-chain fatty acids regulate liver carnitine palmitoyltransferase I gene (L-CPT I) expression through a peroxisome-proliferator-activated receptor alpha (PPARalpha)-independent pathway.

Authors:  J F Louet; F Chatelain; J F Decaux; E A Park; C Kohl; T Pineau; J Girard; J P Pegorier
Journal:  Biochem J       Date:  2001-02-15       Impact factor: 3.857

View more
  19 in total

1.  Nuclear receptor corepressor RIP140 regulates fat accumulation.

Authors:  Göran Leonardsson; Jenny H Steel; Mark Christian; Victoria Pocock; Stuart Milligan; Jimmy Bell; Po-Wah So; Gema Medina-Gomez; Antonio Vidal-Puig; Roger White; Malcolm G Parker
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-20       Impact factor: 11.205

2.  Peroxisome proliferator-activated receptor subtype- and cell-type-specific activation of genomic target genes upon adenoviral transgene delivery.

Authors:  Ronni Nielsen; Lars Grøntved; Hendrik G Stunnenberg; Susanne Mandrup
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

3.  CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity.

Authors:  Naoto Fujiwara; Hayato Nakagawa; Kenichiro Enooku; Yotaro Kudo; Yuki Hayata; Takuma Nakatsuka; Yasuo Tanaka; Ryosuke Tateishi; Yohko Hikiba; Kento Misumi; Mariko Tanaka; Akimasa Hayashi; Junji Shibahara; Masashi Fukayama; Junichi Arita; Kiyoshi Hasegawa; Hadassa Hirschfield; Yujin Hoshida; Yoshihiro Hirata; Motoyuki Otsuka; Keisuke Tateishi; Kazuhiko Koike
Journal:  Gut       Date:  2018-02-06       Impact factor: 23.059

4.  Human HMGCS2 regulates mitochondrial fatty acid oxidation and FGF21 expression in HepG2 cell line.

Authors:  Anna Vilà-Brau; Ana Luísa De Sousa-Coelho; Cristina Mayordomo; Diego Haro; Pedro F Marrero
Journal:  J Biol Chem       Date:  2011-04-18       Impact factor: 5.157

5.  Proteome analysis of liver cells expressing a full-length hepatitis C virus (HCV) replicon and biopsy specimens of posttransplantation liver from HCV-infected patients.

Authors:  Jon M Jacobs; Deborah L Diamond; Eric Y Chan; Marina A Gritsenko; Weijun Qian; Miroslava Stastna; Tracey Baas; David G Camp; Robert L Carithers; Richard D Smith; Michael G Katze
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

6.  Peroxisome proliferator-activated receptor alpha target genes.

Authors:  Maryam Rakhshandehroo; Bianca Knoch; Michael Müller; Sander Kersten
Journal:  PPAR Res       Date:  2010-09-26       Impact factor: 4.964

7.  Functional interaction between peroxisome proliferator-activated receptors-alpha and Mef-2C on human carnitine palmitoyltransferase 1beta (CPT1beta) gene activation.

Authors:  Angel Baldán; Joana Relat; Pedro F Marrero; Diego Haro
Journal:  Nucleic Acids Res       Date:  2004-09-08       Impact factor: 16.971

8.  In vivo role of the HNF4alpha AF-1 activation domain revealed by exon swapping.

Authors:  Nadège Briançon; Mary C Weiss
Journal:  EMBO J       Date:  2006-02-23       Impact factor: 11.598

9.  PPARs: Interference with Warburg' Effect and Clinical Anticancer Trials.

Authors:  Joseph Vamecq; Jean-Marie Colet; Jean Jacques Vanden Eynde; Gilbert Briand; Nicole Porchet; Stéphane Rocchi
Journal:  PPAR Res       Date:  2012-05-08       Impact factor: 4.964

10.  Filling gaps in PPAR-alpha signaling through comparative nutrigenomics analysis.

Authors:  Duccio Cavalieri; Enrica Calura; Chiara Romualdi; Emmanuela Marchi; Marijana Radonjic; Ben Van Ommen; Michael Müller
Journal:  BMC Genomics       Date:  2009-12-11       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.